Natriuretic peptides in vascular physiology and pathology.
Four major natriuretic peptides have been isolated: atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), C-type natriuretic peptide (CNP), and Dendroaspis-type natriuretic peptide (DNP). Natriuretic peptides play an important role in the regulation of cardiovascular homeostasis maintaining blood pressure and extracellular fluid volume. The classical endocrine effects of natriuretic peptides to modulate fluid and electrolyte balance and vascular smooth muscle tone are complemented by autocrine and paracrine actions that include regulation of coronary blood flow and, therefore, myocardial perfusion; modulation of proliferative responses during myocardial and vascular remodeling; and cytoprotective anti-ischemic effects. The actions of natriuretic peptides are mediated by the specific binding of these peptides to three cell surface receptors: type A natriuretic peptide receptor (NPR-A), type B natriuretic peptide receptor (NPR-B), and type C natriuretic peptide receptor (NPR-C). NPR-A and NPR-B are guanylyl cyclase receptors that increase intracellular cGMP concentration and activate cGMP-dependent protein kinases. NPR-C has been presented as a clearance receptor and its activation also results in inhibition of adenylyl cyclase activity. The wide range of effects of natriuretic peptides might be the base for the development of new therapeutic strategies of great benefit in patients with cardiovascular problems including coronary artery disease or heart failure. This review summarizes current literature concerning natriuretic peptides, their receptors and their effects on fluid/electrolyte balance, and vascular and cardiac physiology and pathology, including primary hypertension and myocardial infarction. In addition, we will attempt to provide an update on important issues regarding natriuretic peptides in congestive heart failure.
Woodard
Geoffrey E
GE
National Institute of Allergy and Infectious Diseases, MSC 1876, Bethesda, Maryland 20892-1876, USA.
Rosado
Juan A
JA
D000818:Animals; D001808:Blood Vessels / Q000473:pathology* / Q000502:physiology*; D049109:Cell Proliferation; D006321:Heart / Q000502:physiology; D006801:Humans; D006973:Hypertension / Q000503:physiopathology; D008955:Models, Cardiovascular; D009206:Myocardium / Q000473:pathology; D045265:Natriuretic Peptides / Q000502:physiology*; D018384:Oxidative Stress; D018000:Receptors, Peptide / Q000502:physiology; D015398:Signal Transduction
D045265:Natriuretic Peptides; D018000:Receptors, Peptide